Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Early Stage Breast Cancer
NCT01101438Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Aug 2010
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in breast cancer, sponsored by Canadian Cancer Trials Group. Started Aug 2010; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01101438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01101438.